The University of Southampton
University of Southampton Institutional Repository

Treatment of post-traumatic stress disorder with venlafaxine extended release: a 6-month, randomized, controlled trial

Record type: Article

Context No large-scale posttraumatic stress disorder drug trials have been conducted to evaluate treatment effects beyond 12 weeks outside of those with selective serotonin reuptake inhibitors.
Objective To evaluate the efficacy of venlafaxine extended release (ER), a serotonin norepinephrine reuptake inhibitor, in posttraumatic stress disorder.
Design 6-month, double-blind, placebo-controlled trial.
Setting International study at 56 sites.
Patients Adult outpatients (N = 329) with a primary diagnosis of posttraumatic stress disorder as defined in the DSM-IV, symptoms for 6 months or longer, and a 17-item Clinician-Administered Posttraumatic Stress Disorder Scale score of 60 or higher.
Intervention Patients randomly assigned to receive flexible doses of venlafaxine ER (37.5-300 mg/d) or placebo for 24 weeks.
Main Outcome Measures Primary measure was the change from baseline in the Clinician-Administered Posttraumatic Stress Disorder Scale score. Secondary measures included remission, defined as a Clinician-Administered Posttraumatic Stress Disorder Scale score of 20 or lower, and changes in symptom cluster scores, frequency of remission, and time to remission. Measures of stress vulnerability, resilience, depression, quality of life, functioning, and global illness severity were also taken.
Results Mean changes from baseline in Clinician-Administered Posttraumatic Stress Disorder Scale total scores at end point were –51.7 for venlafaxine ER and –43.9 for placebo (P = .006). Improvement was significantly greater for the venlafaxine ER group than for the placebo group in cluster scores for reexperiencing (P = .008) and avoidance/numbing (P = .006), but not for hyperarousal. Remission rates were 50.9% for venlafaxine ER and 37.5% for placebo (P = .01). The venlafaxine ER group also showed significantly greater improvement at end point than the placebo group (P<.05) on all other reported outcome measures. The mean maximum daily dose of venlafaxine ER was 221.5 mg/d. Withdrawal rates were similar between groups with no significant difference in dropouts attributable to adverse events.
Conclusion In this study, venlafaxine ER was effective and well tolerated in short-term and continuation treatment of patients with posttraumatic stress disorder.

PDF 40587-01.pdf - Version of Record
Restricted to Repository staff only
Download (188kB)

Citation

Davidson, Jonathan, Baldwin, David, Stein, Dan J., Kuper, Enrique, Benattia, Isma, Ahmed, Saeed, Pedersen, Ron and Musgnung, Jeff (2006) Treatment of post-traumatic stress disorder with venlafaxine extended release: a 6-month, randomized, controlled trial Archives of General Psychiatry, 63, (10), pp. 1158-1165. (doi:10.1001/archpsyc.63.10.1158).

More information

Published date: October 2006

Identifiers

Local EPrints ID: 40587
URI: http://eprints.soton.ac.uk/id/eprint/40587
ISSN: 0003-990X
PURE UUID: 6844288c-486a-4b61-b189-60a04a4602c0

Catalogue record

Date deposited: 07 Jul 2006
Last modified: 17 Jul 2017 15:33

Export record

Altmetrics

Contributors

Author: Jonathan Davidson
Author: David Baldwin
Author: Dan J. Stein
Author: Enrique Kuper
Author: Isma Benattia
Author: Saeed Ahmed
Author: Ron Pedersen
Author: Jeff Musgnung

University divisions


Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×